Portable and versatile Point-of-care diagnostics

Expected outcomes

• Projects should contribute to all of the expected outcomes.
• For each outcome (EO1 to EO3), name who will use or adopt your results (a specific group, not “industry” or “society”), how they get them, and the indicator that shows the change, with baseline, target and date.
• Use the topic's own words for each outcome, so the evaluator can tick it off.

What the scope asks for

Evaluators check the proposal against these sentences of the scope. Answer each one visibly, in the call's own words.

• “The selection of the PoC device to be developed or optimised should be based on an objectively conducted clinical needs assessment, which includes -next to clinicians’ perspectives- the complete care pathway and system-level needs.”
• “Moreover, a value-based concept should be applied in the choice and development of the PoC device, taking into account its Health Technology Assessment (HTA) by the relevant HTA bodies, in order to facilitate their decisions for adoption.”
• “Proposals should be driven by a clear clinical need, integrate a value-based concept and include all the following activities:.”
• “In general, priority should be given to approaches that are suitable for resource-limited settings.”
• “In case of targeting infectious diseases, priority should be given to approaches enabling the distinction between viral, bacterial or fungal infections.”
• “In case of targeting non-communicable diseases, priority should be given to approaches that are used in emergency cases where decisions can have life-saving character.”
• “Applicants invited to the second stage and envisaging to include clinical studies should provide details of their clinical studies in the dedicated annex using the template provided in the submission system.”

Conditions that shape the proposal

• Part B, sections 1–3: 45 pages (standard application form). Text beyond the limit is not read; tables and figures count.
• Lump sum: the budget is fixed per work package and paid when each work package is completed. Every work package needs activities and deliverables an evaluator can verify, and the effort must match the money.
• Two-stage submission: the first stage uses a shorter proposal and is assessed on Excellence and Impact only. Check the page limit and sections in the stage-one form of your call.
• Innovation action: evaluators expect a plausible path to commercialisation and named first users or customers.
• Admissibility Conditions, proposal page limit and layout: “Applicants submitting a proposal for a blind evaluation (see General Annex F) must not disclose their organisation names, acronyms, logos nor names of personnel in the proposal abstract and Part B of their first-stage application (see General Annex E).”
• Other Eligibility Conditions: “In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.”
• Other Eligibility Conditions: “In line with the “ restriction on control in innovation actions in critical technology areas ” delineated in General Annex B of the General Annexes, entities established in an eligible country but which are directly or indirectly controlled by China or by a legal entity established in China are not eligible to…”
• Evaluation and award: Award criteria, scoring and thresholds: “The first-stage proposals of this topic will be evaluated blindly.”
• Evaluation and award: Submission and evaluation processes: “For the first stage, the thresholds for each criterion will be 4 (Excellence) and 4 (Impact). The overall threshold applying to the sum of the two individual scores will be set at a level that ensures the total requested budget of proposals admitted to stage 2 is as close as possible to four times the available…”
• Evaluation and award: Submission and evaluation processes: “For the second stage, the thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold will be 12.”

Impact pathway and traps

• Users or citizens are part of the scope. Show how they take part in the design and testing, not only that they are informed.
• The scope expects pilots or demonstration. Name the sites, the partners who run them and what is measured there.
• Policy or regulation is in scope. Name the policy owners you will reach and what you will give them.
• Keep outputs, outcomes and impacts apart: what you deliver, what changes when others use it, and the long-term effect.
• For each destination impact you claim, show which of your outcomes feeds it. Destination impacts are long-term effects, not project deliverables.
• Name the barriers outside the project (regulation, markets, user behaviour) that could block uptake, and what you will do if they do.
• Section 2.3 (the summary canvas) is optional on this call; the old split into scientific, economic and societal impact is no longer required.